Scholarlink

<p>Gut dysbiosis, defined as an imbalance in the gut microbiota’s composition and function, plays a key role in the development of cancer. It alters microbial diversity, disrupts immune function, weakens the gut barrier, and promotes long-term inflammation, contributing to tumour onset and progression. Contributing factors include diet, stress, disrupted sleep, inactivity, antibiotics, environmental exposures, and changes in host genetics or epigenetics. These factors reduce the production of protective microbial byproducts like short-chain fatty acids (SCFAs) and increase the formation of harmful compounds such as nitrosamines and secondary bile acids. Certain bacteria like <i>Fusobacterium nucleatum</i>, <i>Helicobacter pylori</i>, <i>Escherichia coli (pks+), Bacteroides fragilis</i>, and <i>Streptococcus gallolyticus</i> have been linked to cancer through their ability to cause inflammation, damage DNA, or interfere with immune detection. Based on this understanding, approaches such as probiotics, prebiotics, changes in diet, faecal microbiota transplantation (FMT), and targeted microbial treatments are being explored to restore microbial balance and reduce cancer risk. These findings highlight the microbiome’s role in the carcinogenetic pathway.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cancer and the gut microbiome: the oncogenic impact of dysbiosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月24日

查看全文
  • Durre Aden,
  • Kamlesh Darji,
  • Sufian Zaheer

摘要

Gut dysbiosis, defined as an imbalance in the gut microbiota’s composition and function, plays a key role in the development of cancer. It alters microbial diversity, disrupts immune function, weakens the gut barrier, and promotes long-term inflammation, contributing to tumour onset and progression. Contributing factors include diet, stress, disrupted sleep, inactivity, antibiotics, environmental exposures, and changes in host genetics or epigenetics. These factors reduce the production of protective microbial byproducts like short-chain fatty acids (SCFAs) and increase the formation of harmful compounds such as nitrosamines and secondary bile acids. Certain bacteria like Fusobacterium nucleatum, Helicobacter pylori, Escherichia coli (pks+), Bacteroides fragilis, and Streptococcus gallolyticus have been linked to cancer through their ability to cause inflammation, damage DNA, or interfere with immune detection. Based on this understanding, approaches such as probiotics, prebiotics, changes in diet, faecal microbiota transplantation (FMT), and targeted microbial treatments are being explored to restore microbial balance and reduce cancer risk. These findings highlight the microbiome’s role in the carcinogenetic pathway.